PRNewsWire
03 Aug 2026, 15:41 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Supernus Pharmaceuticals (SUPN) has entered into a transaction agreement to merge with Indivior Pharmaceuticals. — M&A activity typically creates a price floor or catalyst for the target company's stock.
+0.30Ademi LLP is investigating Supernus Pharmaceuticals for possible breaches of fiduciary duty and whether shareholders are receiving a fair price in the Indivior deal. — Shareholder litigation can delay deal closure or lead to price renegotiations, creating uncertainty for investors.
-0.20The transaction terms provide for Supernus shareholders to receive 1.5401 shares of Indivior for each Supernus share, resulting in a 43.5% ownership stake in the combined entity. — This defines the concrete exchange ratio and ownership structure for valuation purposes.
+0.10Continue reading
6 related stories
Top 1 mover · tap to explore
The merger agreement includes a significant penalty for Supernus if it accepts a competing bid, which limits the potential for a higher buyout price. — Strong break-up fees deter other suitors from bidding, potentially capping the upside for shareholders.
-0.10Which stocks this story touches
The company is under investigation by Ademi LLP for potential breaches of fiduciary duty.
The company is under investigation by Ademi LLP for potential breaches of fiduciary duty.
The company is under investigation for possible breaches of fiduciary duty regarding a merger transaction.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
GlobeNewsWire
5h ago
